Mucus Relief 600 mg
NDC 53041-190, Guaifenesin, tablet, extended release, from Guardian Drug Company.
- Product NDC
- 53041-190
- Status
- Listed
- Labeler
- Guardian Drug Company
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209215
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53041-190 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53041-190-16 | 53041019016 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (53041-190-16) |
| 53041-190-20 | 53041019020 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (53041-190-20) |
| 53041-190-32 | 53041019032 | 2 BLISTER PACK in 1 CARTON (53041-190-32) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 53041-190-38 | 53041019038 | 4 BLISTER PACK in 1 CARTON (53041-190-38) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 53041-190 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53041-190 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53041-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.